IMARA Inc. (IMRA) News Headlines

▮ More

Date

Headline

11/17/2020 7:11:29 AM Imara Appoints Lynette Hopkinson As SVP Of Regulatory

8/25/2020 7:24:41 AM Imara Receives Orphan Drug Designation From European Commission For IMR-687

8/14/2020 7:13:15 AM Imara Q2 Net Loss Attributable To Stockholders $10.2 Mln Or $0.59/Shr Vs Loss $5.4 Mln Or $7.68/Shr Last Year

6/24/2020 7:14:17 AM IMARA Gets Orphan Drug Designation For IMR-687 For Treatment Of Beta-thalassemia

6/16/2020 1:42:44 AM FDA Nod For JAZZ's Drug, BYSI's PROTECTIVE-2 Trial Meets Goals, EDSA To Begin COVID-19 Drug Trial

6/4/2020 11:32:57 PM CYCN Awaits Sickle Cell Disease Data, TTPH Finalizes Its Suitor, ADMS Faces FDA In Feb

6/4/2020 12:37:03 AM List Of 'Operation Warp Speed' Finalists, SAVA To Reassess AD Study Results; KZR Jumps On MISSION

5/28/2020 11:35:21 PM ABIO Jumps On Joining COVID-19 Drug Fray, GMAB Hits Trial Goal, IMRA On Watch

5/4/2020 7:19:26 AM Imara Appoints Stephen Migausky As General Counsel

4/29/2020 6:08:05 AM Do You Have These Stocks In Your Portfolio? (SNDX, ERYP, IMRA...)

3/12/2020 1:12:21 AM IMARA Prices IPO At $16/Shr, At Low End Of Expected Range

3/8/2020 12:53:02 AM Biopharma Company Imara Inc To Make U.S. Trading Debut On March 12

Older Articles Latest Headlines

Imara Inc. (IMRA)